Petros pharmaceuticals reports year end 2021 financial results and corporate highlights

New york, april 01, 2022 (globe newswire) -- petros pharmaceuticals, inc. (“petros” or “the company”) (nasdaq: ptpi), a leading provider of therapeutics for men's health, today announces financial results for the fiscal year ended december 31, 2021.
PTPI Ratings Summary
PTPI Quant Ranking